Shaker SB - Search Results

1

Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results.

Salih GN, Shaker SB, Madsen HD, Bendstrup E. Salih GN, et al. Among authors: shaker sb. Eur Clin Respir J. 2016 Sep 9;3:32608. doi: 10.3402/ecrj.v3.32608. eCollection 2016. Eur Clin Respir J. 2016. PMID: 27616539 Free PMC article.

2

Quantitative computed tomography and aerosol morphometry in COPD and alpha1-antitrypsin deficiency.

Shaker SB, Maltbaek N, Brand P, Haeussermann S, Dirksen A. Shaker SB, et al. Eur Respir J. 2005 Jan;25(1):23-30. doi: 10.1183/09031936.04.00075304. Eur Respir J. 2005. PMID: 15640319 Free article.

3

Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.

Dirksen A, Piitulainen E, Parr DG, Deng C, Wencker M, Shaker SB, Stockley RA. Dirksen A, et al. Among authors: shaker sb. Eur Respir J. 2009 Jun;33(6):1345-53. doi: 10.1183/09031936.00159408. Epub 2009 Feb 5. Eur Respir J. 2009. PMID: 19196813 Free article. Clinical Trial.

4

Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.

Shaker SB, von Wachenfeldt KA, Larsson S, Mile I, Persdotter S, Dahlbäck M, Broberg P, Stoel B, Bach KS, Hestad M, Fehniger TE, Dirksen A. Shaker SB, et al. Clin Respir J. 2008 Jan;2(1):17-25. doi: 10.1111/j.1752-699X.2007.00032.x. Clin Respir J. 2008. PMID: 20298300

5

The extent of emphysema in patients with COPD.

Shaker SB, Stavngaard T, Hestad M, Bach KS, Tonnesen P, Dirksen A. Shaker SB, et al. Clin Respir J. 2009 Jan;3(1):15-21. doi: 10.1111/j.1752-699X.2008.00102.x. Clin Respir J. 2009. PMID: 20298367

6

Factors influencing the decline in lung density in a Danish lung cancer screening cohort.

Shaker SB, Dirksen A, Lo P, Skovgaard LT, de Bruijne M, Pedersen JH. Shaker SB, et al. Eur Respir J. 2012 Nov;40(5):1142-8. doi: 10.1183/09031936.00207911. Epub 2012 Mar 9. Eur Respir J. 2012. PMID: 22408202 Free article.

7

Profuse coarse pulmonary nodules in a patient with lymphangioleiomyomatosis: thirty-three years of follow-up.

Rasmussen DB, Shaker SB, Seersholm N, Colella S, Clementsen PF. Rasmussen DB, et al. Among authors: shaker sb. Eur Clin Respir J. 2014 Dec 9;1. doi: 10.3402/ecrj.v1.26272. eCollection 2014. Eur Clin Respir J. 2014. PMID: 26557233 Free PMC article.

8

Rituximab-induced interstitial lung disease: five case reports.

Naqibullah M, Shaker SB, Bach KS, Bendstrup E. Naqibullah M, et al. Among authors: shaker sb. Eur Clin Respir J. 2015 May 21;2. doi: 10.3402/ecrj.v2.27178. eCollection 2015. Eur Clin Respir J. 2015. PMID: 26557260 Free PMC article.

9

The lived experience with idiopathic pulmonary fibrosis: a qualitative study.

Overgaard D, Kaldan G, Marsaa K, Nielsen TL, Shaker SB, Egerod I. Overgaard D, et al. Among authors: shaker sb. Eur Respir J. 2016 May;47(5):1472-80. doi: 10.1183/13993003.01566-2015. Epub 2016 Feb 4. Eur Respir J. 2016. PMID: 26846831 Free article.

10

[Treatment limitations or discontinuation in patients with benign pulmonary diseases].

Sørensen AR, Bendstrup E, Løkke A, Titlestad IL, Jensen JU, Thomsen L, Roberts N, Gjørup P, Shaker S, Gundestrup S, Wilcke T, Weinreich UM, Marsaa K. Sørensen AR, et al. Ugeskr Laeger. 2018 Sep 24;180(39):V04180270. Ugeskr Laeger. 2018. PMID: 30274574 Free article. Review. Danish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters